TY  - JOUR
AU  - Ribera, Jordi
AU  - Granada, Isabel
AU  - Morgades, Mireia
AU  - González, Teresa
AU  - Ciudad, Juana
AU  - Such, Esperanza
AU  - Calasanz, María-José
AU  - Mercadal, Santiago
AU  - Coll, Rosa
AU  - González-Campos, José
AU  - Tormo, Mar
AU  - García-Cadenas, Irene
AU  - Gil, Cristina
AU  - Cervera, Marta
AU  - Barba, Pere
AU  - Costa, Dolors
AU  - Ayala, Rosa
AU  - Bermúdez, Arancha
AU  - Orfao, Alberto
AU  - Ribera, Josep-Maria
AU  - Programa para el Tratamiento de Hemopatias Malignas (PETHEMA) Group (Spanish Society of Hematology, SEHH)
PY  - 2021
DO  - 10.1111/bjh.17844
UR  - http://hdl.handle.net/10668/18532
T2  - British journal of haematology
AB  - The prognosis of t(1;19)(q23;p13)/transcription factor 3-pre-B-cell leukaemia homeobox 1 (TCF3-PBX1) in adolescent and adult patients with acute lymphoblastic leukaemia (ALL) treated with measurable residual disease (MRD)-oriented trials remains...
LA  - en
KW  - acute lymphoblastic leukaemia
KW  - adults
KW  - cytogenetic alterations
KW  - prognosis
KW  - t(1;19)(q23;p13)/TCF3-PBX1
KW  - Adolescent
KW  - Adult
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Chromosome Banding
KW  - Chromosomes, Human, Pair 1
KW  - Chromosomes, Human, Pair 19
KW  - Disease Management
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Neoplasm Staging
KW  - Neoplasm, Residual
KW  - Oncogene Proteins, Fusion
KW  - Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
KW  - Prognosis
KW  - Remission Induction
KW  - Translocation, Genetic
KW  - Treatment Outcome
KW  - Young Adult
TI  - Prognostic heterogeneity of adult B-cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3-PBX1 treated with measurable residual disease-oriented protocols.
TY  - research article
VL  - 196
ER  -